By Kelly Lienhard ( September 14, 2023, 6:00 PM EDT) -- The Federal Trade Commission voted unanimously Thursday to issue a policy statement cautioning drug manufacturers against listing noncompliant drug patents in the U.S. Food and Drug Administration's Orange Book, part of a recent push to encourage competition, increase access to essential medications and mitigate rising costs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.